ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

TNYA Tenaya Therapeutics Inc

4.68
0.12 (2.63%)
Fuera de horario
Última actualización: 16:16:11
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Tenaya Therapeutics Inc TNYA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.12 2.63% 4.68 16:16:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.58 4.47 4.81 4.68 4.56
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/3/202415:05GLOBETenaya Therapeutics Reports Fourth Quarter and Full Year..
18/3/202407:30GLOBETenaya Therapeutics Announces Publication of TN-401 Gene..
27/2/202418:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:30GLOBETenaya Therapeutics to Participate in Upcoming March..
26/2/202407:30GLOBETenaya Therapeutics Announces Publication of Preclinical..
16/2/202419:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202419:13EDGAR2Form 144 - Report of proposed sale of securities
08/2/202416:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202407:15EDGAR2Form 8-K - Current report
08/2/202407:00GLOBETenaya Therapeutics Announces Pricing of Underwritten..
31/1/202415:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/1/202407:30GLOBETenaya Therapeutics to Participate at the 42nd Annual J.P...
21/11/202315:30GLOBETenaya Therapeutics to Participate at the 35th Annual Piper..
08/11/202315:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:12EDGAR2Form 8-K - Current report
08/11/202315:05GLOBETenaya Therapeutics Reports Third Quarter 2023 Financial..
26/10/202307:30GLOBETenaya Therapeutics Announces FDA Clearance to Begin..
09/10/202307:30GLOBETenaya Therapeutics Presents Encouraging New Clinical and..
05/10/202307:30GLOBETenaya Therapeutics Doses First Patient in the MyPeak-1™..
02/10/202316:30GLOBETenaya Therapeutics Publishes Preclinical Data in..
21/9/202315:05GLOBETenaya Therapeutics to Present Data for TN-301 and TN-201 at..
31/8/202315:05GLOBETenaya Therapeutics to Participate at the 21st Annual Morgan..
18/8/202317:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202320:10EDGAR2Form 144 - Report of proposed sale of securities
09/8/202315:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:19EDGAR2Form 8-K - Current report
09/8/202315:05GLOBETenaya Therapeutics Reports Second Quarter 2023 Financial..
02/8/202315:05GLOBETenaya Therapeutics to Participate at the 43rd Annual..
10/5/202315:19GLOBETenaya Therapeutics Reports First Quarter 2023 Financial..
03/5/202307:00GLOBETenaya Highlights Growing Capabilities in AAV Manufacturing,..
02/5/202307:43DJNTenaya Therapeutics Gets FDA Fast-Track Designation for..
02/5/202306:50GLOBETenaya Therapeutics Receives FDA Fast Track Designation for..

Su Consulta Reciente

Delayed Upgrade Clock